158 related articles for article (PubMed ID: 12658446)
1. NK1, NK2, NK3 and CGRP1 receptors identified in rat oral soft tissues, and in bone and dental hard tissue cells.
Fristad I; Vandevska-Radunovic V; Fjeld K; Wimalawansa SJ; Hals Kvinnsland I
Cell Tissue Res; 2003 Mar; 311(3):383-91. PubMed ID: 12658446
[TBL] [Abstract][Full Text] [Related]
2. Effect of neurokinins on canine prostate cell physiology.
Walden PD; Marinese D; Srinivasan D; Tzoumaka E; Syyong HT; Ford AP; Bhattacharya A
Prostate; 2005 Jun; 63(4):358-68. PubMed ID: 15611996
[TBL] [Abstract][Full Text] [Related]
3. Distribution of substance P and neurokinin-1 receptors in the peri-implant epithelium around titanium dental implants in rats.
Yamaza T; Kido MA; Wang B; Danjo A; Shimohira D; Murata N; Yoshinari M; Tanaka T
Cell Tissue Res; 2009 Feb; 335(2):407-15. PubMed ID: 19015883
[TBL] [Abstract][Full Text] [Related]
4. Differential expression of Nk1 and NK3 neurokinin receptors in neurons of the nucleus tractus solitarius and the dorsal vagal motor nucleus of the rat and mouse.
Le Brun I; Dufour A; Crest M; Szabó G; Erdelyi F; Baude A
Neuroscience; 2008 Mar; 152(1):56-64. PubMed ID: 18222044
[TBL] [Abstract][Full Text] [Related]
5. Distinct regional distributions of NK1 and NK3 neurokinin receptor immunoreactivity in rat brainstem gustatory centers.
Harrison TA; Hoover DB; King MS
Brain Res Bull; 2004 Mar; 63(1):7-17. PubMed ID: 15121234
[TBL] [Abstract][Full Text] [Related]
6. The NK1 receptor and its participation in the synergistic enhancement of corneal epithelial migration by substance P and insulin-like growth factor-1.
Nakamura M; Ofuji K; Chikama T; Nishida T
Br J Pharmacol; 1997 Feb; 120(4):547-52. PubMed ID: 9051288
[TBL] [Abstract][Full Text] [Related]
7. MEN15596, a novel nonpeptide tachykinin NK2 receptor antagonist.
Cialdai C; Tramontana M; Patacchini R; Lecci A; Catalani C; Catalioto RM; Meini S; Valenti C; Altamura M; Giuliani S; Maggi CA
Eur J Pharmacol; 2006 Nov; 549(1-3):140-8. PubMed ID: 16979621
[TBL] [Abstract][Full Text] [Related]
8. Species differences in tachykinin receptor distribution: further evidence that the substance P (NK1) receptor predominates in human brain.
Rigby M; O'Donnell R; Rupniak NM
J Comp Neurol; 2005 Oct; 490(4):335-53. PubMed ID: 16127708
[TBL] [Abstract][Full Text] [Related]
9. CGRP1 and NK1 receptors in postnatal, developing rat dental tissues.
Vandevska-Radunovic V; Fristad I; Wimalawansa SJ; Kvinnsland IH
Eur J Oral Sci; 2003 Dec; 111(6):497-502. PubMed ID: 14632686
[TBL] [Abstract][Full Text] [Related]
10. Changes in tracheo-bronchial sensory neuropeptide receptor gene expression pattern in rats with cisplatin-induced sensory neuropathy.
Horváth P; Szilvássy Z; Peitl B; Szilvássy J; Helyes Z; Szolcsányi J; Németh J
Neuropeptides; 2006 Feb; 40(1):77-83. PubMed ID: 16343617
[TBL] [Abstract][Full Text] [Related]
11. Tachykinins and tachykinin-receptors in the rat pineal gland.
Mukda S; Chetsawang B; Govitrapong P; Schmidt PT; Hay-Schmidt A; Møller M
Eur J Neurosci; 2005 May; 21(10):2743-51. PubMed ID: 15926922
[TBL] [Abstract][Full Text] [Related]
12. A role for tachykinins in female mouse and rat reproductive function.
Pintado CO; Pinto FM; Pennefather JN; Hidalgo A; Baamonde A; Sanchez T; Candenas ML
Biol Reprod; 2003 Sep; 69(3):940-6. PubMed ID: 12773411
[TBL] [Abstract][Full Text] [Related]
13. Characterization of antisera specific to NK1, NK2, and NK3 neurokinin receptors and their utilization to localize receptors in the rat gastrointestinal tract.
Grady EF; Baluk P; Böhm S; Gamp PD; Wong H; Payan DG; Ansel J; Portbury AL; Furness JB; McDonald DM; Bunnett NW
J Neurosci; 1996 Nov; 16(21):6975-86. PubMed ID: 8824334
[TBL] [Abstract][Full Text] [Related]
14. Tachykinins and tachykinin receptors in the gut, with special reference to NK2 receptors in human.
Lecci A; Capriati A; Altamura M; Maggi CA
Auton Neurosci; 2006 Jun; 126-127():232-49. PubMed ID: 16616700
[TBL] [Abstract][Full Text] [Related]
15. SSR240600 [(R)-2-(1-[2-[4-[2-[3,5-bis(trifluoromethyl)phenyl]acetyl]-2-(3,4-dichlorophenyl)-2-morpholinyl]ethyl]- 4-piperidinyl)-2-methylpropanamide], a centrally active nonpeptide antagonist of the tachykinin neurokinin-1 receptor: I. biochemical and pharmacological characterization.
Emonds-Alt X; Proietto V; Steinberg R; Oury-Donat F; Vigé X; Vilain P; Naline E; Daoui S; Advenier C; Le Fur G; Maffrand JP; Soubrié P; Pascal M
J Pharmacol Exp Ther; 2002 Dec; 303(3):1171-9. PubMed ID: 12438541
[TBL] [Abstract][Full Text] [Related]
16. Postnatal development of NK1, NK2, and NK3 neurokinin receptors expression in the rat retina.
Oyamada H; Takatsuji K; Senba E; Mantyh PW; Tohyama M
Brain Res Dev Brain Res; 1999 Oct; 117(1):59-70. PubMed ID: 10536233
[TBL] [Abstract][Full Text] [Related]
17. [Functional properties of tachykinin receptors in the central nervous system].
Glowinski J; Beaujouan JC
C R Seances Soc Biol Fil; 1993; 187(1):62-8. PubMed ID: 8242423
[TBL] [Abstract][Full Text] [Related]
18. Pharmacologic characterization of receptor types mediating coronary vasodilator actions of sensory neuropeptides in the guinea pig.
Lam FF
J Cardiovasc Pharmacol; 2000 Apr; 35(4):646-52. PubMed ID: 10774797
[TBL] [Abstract][Full Text] [Related]
19. Neurokinin receptor modulation of respiratory activity in the rabbit.
Bongianni F; Mutolo D; Cinelli E; Pantaleo T
Eur J Neurosci; 2008 Jun; 27(12):3233-43. PubMed ID: 18554294
[TBL] [Abstract][Full Text] [Related]
20. Neurokinins robustly activate the majority of septohippocampal cholinergic neurons.
Morozova E; Wu M; Dumalska I; Alreja M
Eur J Neurosci; 2008 Jan; 27(1):114-22. PubMed ID: 18184316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
